|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| A61K 39/3955 | (2013.01) | ||
| C07K 16/24 | (2006.01) | ||
| A61K 31/00 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61K 35/17 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C07K 16/248 | (2013.01) | ||
| C07K 14/00 | (2006.01) | ||
| C07K 14/00 | (2013.01) | ||
| C12N 15/113 | (2010.01) | ||
| C12N 15/113 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/70 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3551294 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17825416.5 |
| Date of filing the European patent application | 2017-12-11 | |
| (97) | Date of publication of the European application | 2019-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/082234 |
| Date | 2017-12-11 |
| (87) | Number | WO 2018/104554 |
| Date | 2018-06-14 |
| (30) | Number | Date | Country code |
| 201662432334 P | 2016-12-09 | US | |
| 17179414 | 2017-07-03 | EP |
| (72) |
O'DWYER, Michael Eamon Peter , IE
HU, Jinsong , CN
|
| (73) |
ONK Therapeutics Limited ,
C/O Coll & Company
Pier Road
Barna Village, Co. Galway H91 V6KV,
IE
|
| (54) | IMPROVED NK-BASED CELL THERAPY |
| IMPROVED NK-BASED CELL THERAPY |